Join to View Full Profile
3311 E Murdock StWichita, KS 67208
Phone+1 316-689-9185
Fax+1 316-689-9909
Dr. Lyddane is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Clay Lyddane, MD, is a urologist based in Wichita, KS, specializing in urologic trauma and reconstructive surgery, men's health, kidney and ureteral stones, metabolic stone disease, and urethral reconstruction. He completed his medical education at Weill Cornell Medicine in 2006, followed by a surgery residency and a urology residency at the Icahn School of Medicine at Mount Sinai. Dr. Lyddane has contributed to several research publications, with notable works published in prominent journals such as the Journal of Immunology and Nature Medicine. His research has been widely cited, demonstrating his involvement in advancing the field. He also received the CMS Meaningful Use Stage 1 Certification from NextGen Healthcare in 2012-2013.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Urology, 2007 - 2011- Icahn School of Medicine at Mount SinaiResidency, Surgery, 2006 - 2007
Weill Cornell MedicineClass of 2006
Certifications & Licensure
CO State Medical License 2024 - 2027
KS State Medical License 2011 - 2024
NY State Medical License 2008 - 2012
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2013-2017
Publications & Presentations
PubMed
- 15 citationsCutting Edge: CD28 Controls Dominant Regulatory T Cell Activity during Active ImmunizationClay Lyddane, Beata U. Gajewska, Elmer Santos, Philip D. King, Glaucia C. Furtado
Journal of Immunology. 2006-03-15 - 94 citationsTargeted elimination of prostate cancer by genetically directed human T lymphocytes.Terence P. Gade, Waleed A. Hassen, Elmer Santos, Gertrude Gunset, Aurore Saudemont
Cancer Research. 2005-10-01 - 26 citationsC-type lectin OCILRP2/Clr-g and its ligand NKRP1f costimulate T cell proliferation and IL-2 production.Wenzhi Tian, Rafael Nunez, Shuhua Cheng, Yumei Ding, Joseph R. Tumang
Cellular Immunology. 2005-03-01
Press Mentions
Via Christi Hospitals Wichita : AMG via Christi Wichita Area's First to Offer Innovative Treatment for Benign Prostatic HyperplasiaJune 6th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
